Table 4.
POAG | PACG | NTG | Overall | |
---|---|---|---|---|
Case number | 28 | 27 | 5 | |
IOP at presentation (mmHg) | 24.3±10.0 | 19.7±7.4 | 18.6±11.3 | 21.7±9.2 |
Baseline BCVA (Snellen) | 0.027 | 0.015 | 0.023 | 0.02 |
Final BCVA (Snellen) | 0.018 | 0.013 | 0.005 | 0.014 |
Cup-to-disc ratio | ||||
Initial (mean±SD) | 0.69±0.17 | 0.72±0.16 | 0.88±0.04 | 0.72±0.16 |
Final (mean±SD) | 0.75±0.16 | 0.77±0.14 | 0.88±0.04 | 0.77±0.15 |
p value † | 0.01 | 0.036 | 0.001 | |
Follow-up (months) (mean±SD) | 30.1±26.9 | 32.3±32.8 | 25.8±22.7 | 30.8±29.1 |
Abbreviations: BCVA best-corrected visual acuity, NVG neovascular glaucoma, PACG primary angle closure glaucoma, POAG primary open angle glaucoma, and SD standard deviation.
†Changes betweenthe initial and final cup-to-disc ratio were examined using the Wilcoxon signed-rank test.